does tirzepatide burn visceral fat How Helps Lose Weight & Improve Metabolic Health Tirzepatide Benefits for Men: Fat

FDA Clears First Oral GLP-1 for Weight Loss On December 22, 2025, the FDA approved Novo Nordisks once-daily Wegovy pill (25 mg semaglutide), the first oral GLP-1 receptor agonist indicated for chronic weight management and cardiovascular risk reduction in adults with obesity or overweight plus at least one weight-related comorbidity

The lacrimal glands secrete a mixture of water, electrolytes, and proteins, which contribute to the formation of tears

Travel and time zone changes Traveling across time zones disrupts your circadian rhythm, and your skin's rhythm along with it

While it is FDA-approved to treat high blood pressure, heart failure, and edema (fluid retention), it is very commonly used off-label by healthcare providers to treat hormonal issues in women